Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 352 entries
View as:

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT00151918 Org: User:
Start: 01/07/05 End: 08/22/05 Due: 08/22/06

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Phase: N/A Priority: Normal
NCT ID: NCT02954458 Org: User:
Start: 01/09/17 End: 11/05/20 Due: 11/05/21

Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT03327402 Org: User:
Start: 03/13/18 End: 10/05/18 Due: 10/05/19

SSP-002358 Drug Interaction Study With Omeprazole

Phase: N/A Priority: Normal
NCT ID: NCT01415349 Org: User:
Start: 08/11/11 End: 09/28/11 Due: 09/28/12

A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01923207 Org: User:
Start: 08/12/13 End: 01/07/14 Due: 01/07/15

SPD544 High Strength Bioequivalence Study

Phase: N/A Priority: Normal
NCT ID: NCT01183234 Org: User:
Start: 08/27/10 End: 10/22/10 Due: 10/22/11

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

Phase: N/A Priority: Normal
NCT ID: NCT01304277 Org: User:
Start: 11/17/11 End: 12/28/12 Due: 12/28/13

Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01685216 Org: User:
Start: 09/14/12 End: 03/15/15 Due: 03/15/16

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04497883 Org: User:
Start: 08/07/20 End: 11/12/20 Due: 11/12/21

A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators

Phase: N/A Priority: Normal
NCT ID: NCT00458445 Org: User:
Start: 04/30/07 End: 06/15/07 Due: 06/15/08

Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT02781844 Org: User:
Start: 04/03/17 End: 03/08/19 Due: 03/08/20

Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)

Phase: N/A Priority: Normal
NCT ID: NCT04636502 Org: User:
Start: 02/08/21 End: 09/14/21 Due: 09/14/22

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00882687 Org: User:
Start: 04/24/09 End: 05/10/09 Due: 05/10/10

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01506141 Org: User:
Start: 08/01/10 End: 04/30/24 Due: 04/30/25

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02055118 Org: User:
Start: 03/24/14 End: 09/28/17 Due: 09/28/18

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02466386 Org: User:
Start: 08/21/15 End: 01/03/20 Due: 01/03/21

Safety Study of Replagal® Therapy in Children With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT01363492 Org: User:
Start: 05/12/11 End: 04/17/13 Due: 04/17/14

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT00160121 Org: User:
Start: 01/10/05 End: 12/13/05 Due: 12/13/06

An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00635427 Org: User:
Start: 03/13/08 End: 12/28/12 Due: 12/28/13

A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved

Phase: N/A Priority: Normal
NCT ID: NCT02605837 Org: User:
Start: 12/07/15 End: 02/15/19 Due: 02/15/20

Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease

Phase: N/A Priority: Normal
NCT ID: NCT02060526 Org: User:
Start: 02/26/14 End: 06/01/16 Due: 06/01/17

A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00172107 Org: User:
Start: 05/18/95 End: 03/24/97 Due: 03/24/98

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Phase: N/A Priority: Normal
NCT ID: NCT01081132 Org: User:
Start: 09/19/11 End: 05/16/13 Due: 05/16/14

ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study

Phase: N/A Priority: Normal
NCT ID: NCT04440488 Org: User:
Start: 03/08/21 End: 09/12/25 Due: 09/12/26

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01696279 Org: User:
Start: 02/15/13 End: 11/16/18 Due: 11/16/19